<DOC>
	<DOCNO>NCT01558466</DOCNO>
	<brief_summary>This study hop evaluate effectiveness early combine use Sildenafil nitric oxide ( iNO ) newborns Persistent pulmonary hypertension ( PPHN ) hypoxemic respiratory failure ass whether would improve oxygenation , improve time mechanical ventilation baby also prevent rebound hypoxic episode .</brief_summary>
	<brief_title>Sildenofil Persistent Pulmonary Hypertension Newborns</brief_title>
	<detailed_description>PPHN characterize hyper reactivity muscle layer pulmonary arteriole right leave shunt across ductus arteriosus foramen ovale absence structural heart defect . It could also include right ventricle dysfunction many case . The report incidence disease 0.43 6.8/1000 live new bear infant mortality 10-20 % . The main objective therapy PPHN reduce pulmonary vascular resistance . To purpose , inhale nitric oxide use develop several developed country . However 30-40 % patient respond therapy . Extra corporeal membrane oxygenation also useful invasive therapy PPHN serious adverse effect report . Recently Sildenafil evaluate alternative adjunctive pulmonary vasodilator . It inhibit phosphodiesterase type 5 elevates concentration cyclic guanosine monophosphate muscle cell pulmonary vessel , turn decrease pulmonary vascular resistance . The FDA USA recently approve use Sildenafil use adult PPHN . Recently 3 clinical trial evaluate Sildenafil versus Placebo control newborns PPHN , show significant improvement oxygenation index , decrease mortality reduce risk rebound discontinue iNO . The use Sildenafil treat PPHN secondary Chronic lung disease old infant receive significant attention last year . At HMC , Women 's hospital , number delivery average 15,000 16,000 per year admission rate NICU 10 % . The number PPHN case admit NICU range 14-20 case per year . In study investigator plan compare effectiveness use early combine Sildenafil iNO newborn PPHN hypoxemic respiratory failure whether would improve oxygenation , decrease time spent mechanical ventilation prevent rebound hypoxic episode .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hypertension , Pulmonary</mesh_term>
	<mesh_term>Persistent Fetal Circulation Syndrome</mesh_term>
	<mesh_term>Sildenafil Citrate</mesh_term>
	<criteria>1 . Newborn infant post natal age le 48 hour 2 . Gestational age equal 34 week 3 . Oxygen index equal 20 ( moderately ill infant ) 4 . Radiological , clinical biochemical evidence acute hypoxic respiratory failure 5 . Surfactant therapy establish indicate 6 . Presence arterial line 1 . Congenital diaphragmatic hernia 2 . Major congenital abnormality 3 . Significant congenital heart disease 4 . Cyanotic congenital heart disease</criteria>
	<gender>All</gender>
	<minimum_age>36 Weeks</minimum_age>
	<maximum_age>41 Weeks</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>newborn</keyword>
	<keyword>INO</keyword>
	<keyword>Sildenafil</keyword>
	<keyword>PPHN</keyword>
</DOC>